Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prana Biotechnology Ltd (NASDAQ:PRAN)

2.93
Delayed Data
As of Apr 21
 +0.10 / +3.53%
Today’s Change
1.52
Today|||52-Week Range
6.69
+79.75%
Year-to-Date
Institutional investors purchased a net $9.7 thousand shares of PRAN during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 2.36% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional2.29%
Mutual fund holders0.06%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Prana Biotechnology Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Morgan Stanley & Co. LLC1.37%121,555380,467+5,900+5.10%
Citadel Advisors LLC0.26%23,28072,866+23,280--
KCG Americas LLC0.26%23,09772,294+3,307+16.71%
Deutsche Asset Management Investm...0.22%19,40260,728+1,001+5.44%
Renaissance Technologies LLC0.18%16,29551,003-2,922-15.21%
Advantage Investment Management L...0.01%1,1153,490-333-23.00%
Wells Fargo Clearing Services LLC0.01%8332,607-749-47.35%
MetLife Securities, Inc.0.01%5001,56500.00%
Royal Alliance Associates, Inc.0.01%5001,56500.00%
Tower Research Capital LLC0.01%5091,593+509--

Top 10 Mutual Funds Holding Prana Biotechnology Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Trust for Professional Managers -...0.04%3,80111,897+3,801--
Fidelity Nasdaq Composite Index T...0.01%1,1573,621+29+2.57%
Fidelity Nasdaq Composite Index F...0.01%5481,71500.00%
European Wealth Investment Fund P...0.00%00-1,029-100.00%